NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

Federal funding opportunity RFA-HL-26-003 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes April 28, 2027

Program funding history

Synopsis

Who can apply

• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Special district governments
• Public and State controlled institutions of higher education
• Independent school districts
• Private institutions of higher education
• Small businesses
• Public housing authorities/Indian housing authorities
• Native American tribal organizations (other than Federally recognized tribal governments)
• State governments
• County governments
• City or township governments
• Native American tribal governments (Federally recognized)
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• For profit organizations other than small businesses

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

How to apply

Similar grants

• NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
  RFA-HL-26-002 · National Institutes of Health · closes April 28, 2027
• Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)
  PA-24-187 · National Institutes of Health · closes May 7, 2027
• Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)
  PA-24-188 · National Institutes of Health · closes May 7, 2027
• NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
  PAR-24-209 · National Institutes of Health · closes July 12, 2027
• NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
  PAR-24-211 · National Institutes of Health · closes July 12, 2027
• NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
  PAR-25-025 · National Institutes of Health · closes January 7, 2027